Literature DB >> 19695656

Functional and genetic analysis of coreceptor usage by dualtropic HIV-1 subtype C isolates.

Ashika Singh1, Taryn Page, Penny L Moore, Rachel L Allgaier, Keshni Hiramen, Hoosen M Coovadia, Bruce D Walker, Lynn Morris, Thumbi Ndung'u.   

Abstract

It is widely documented that a complete switch from the predominant CCR5 (R5) to CXCR4 (X4) phenotype is less common for HIV-1 subtype C (HIV-1C) compared to other major subtypes. We investigated whether dualtropic HIV-1C isolates represented dualtropic, mixed R5 and X4 clones or both. Thirty of 35 functional HIV-1 env clones generated by bulk PCR amplification from peripheral blood mononuclear cells (PBMCs) infected with seven dualtropic HIV-1C isolates utilized CXCR4 exclusively. Five of 35 clones displayed dualtropism. Endpoint dilution of one isolate did not yield a substantial proportion of R5-monotropic env clones. Sequence-based predictive algorithms showed that env sequences from PBMCs, CXCR4 or CCR5-expressing cell lines were indistinguishable and all possessed X4/dualtropic characteristics. We describe HIV-1C CXCR4-tropic env sequence features. Our results suggest a dramatic loss of CCR5 monotropism as dualtropism emerges in HIV-1C which has important implications for the use of coreceptor antagonists in therapeutic strategies for this subtype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19695656      PMCID: PMC3492694          DOI: 10.1016/j.virol.2009.07.021

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  59 in total

1.  Change in co-receptor usage of current South African HIV-1 subtype C primary isolates.

Authors:  Estrelita Janse van Rensburg; Tracey-Lee Smith; Michelle Zeier; Brenda Robson; Candice Sampson; Florette Treurnicht; Susan Engelbrecht
Journal:  AIDS       Date:  2002-12-06       Impact factor: 4.177

2.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.

Authors:  T Dragic; V Litwin; G P Allaway; S R Martin; Y Huang; K A Nagashima; C Cayanan; P J Maddon; R A Koup; J P Moore; W A Paxton
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

3.  The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop.

Authors:  T M Ross; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

4.  A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding.

Authors:  C D Rizzuto; R Wyatt; N Hernández-Ramos; Y Sun; P D Kwong; W A Hendrickson; J Sodroski
Journal:  Science       Date:  1998-06-19       Impact factor: 47.728

5.  A new classification for HIV-1.

Authors:  E A Berger; R W Doms; E M Fenyö; B T Korber; D R Littman; J P Moore; Q J Sattentau; H Schuitemaker; J Sodroski; R A Weiss
Journal:  Nature       Date:  1998-01-15       Impact factor: 49.962

6.  Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.

Authors:  J He; S Choe; R Walker; P Di Marzio; D O Morgan; N R Landau
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.

Authors:  R Wyatt; J Moore; M Accola; E Desjardin; J Robinson; J Sodroski
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

Review 8.  Chemokine receptor CCR5: insights into structure, function, and regulation.

Authors:  Martin Oppermann
Journal:  Cell Signal       Date:  2004-11       Impact factor: 4.315

9.  The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C.

Authors:  Tonie Cilliers; Jabulani Nhlapo; Mia Coetzer; Dragana Orlovic; Thomas Ketas; William C Olson; John P Moore; Alexandra Trkola; Lynn Morris
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

10.  Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing.

Authors:  Jesus F Salazar-Gonzalez; Elizabeth Bailes; Kimmy T Pham; Maria G Salazar; M Brad Guffey; Brandon F Keele; Cynthia A Derdeyn; Paul Farmer; Eric Hunter; Susan Allen; Olivier Manigart; Joseph Mulenga; Jeffrey A Anderson; Ronald Swanstrom; Barton F Haynes; Gayathri S Athreya; Bette T M Korber; Paul M Sharp; George M Shaw; Beatrice H Hahn
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

View more
  9 in total

1.  Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C.

Authors:  Mia Coetzer; Rebecca Nedellec; Tonie Cilliers; Tammy Meyers; Lynn Morris; Donald E Mosier
Journal:  J Acquir Immune Defic Syndr       Date:  2011-01-01       Impact factor: 3.731

2.  Drug resistance and coreceptor usage in HIV type 1 subtype C-infected children initiating or failing highly active antiretroviral therapy in South Africa.

Authors:  Taryn N Green; Mohendran Archary; Michelle L Gordon; Nagavelli Padayachi; Yolanda Lie; Elizabeth D Anton; Jacqueline D Reeves; Anneke Grobler; Raziya Bobat; Hoosen Coovadia; Thumbi Ndung'u
Journal:  AIDS Res Hum Retroviruses       Date:  2011-08-05       Impact factor: 2.205

3.  Drug resistance and viral tropism in HIV-1 subtype C-infected patients in KwaZulu-Natal, South Africa: implications for future treatment options.

Authors:  Ashika Singh; Henry Sunpath; Taryn N Green; Nagavelli Padayachi; Keshni Hiramen; Yolanda Lie; Elizabeth D Anton; Richard Murphy; Jacqueline D Reeves; Daniel R Kuritzkes; Thumbi Ndung'u
Journal:  J Acquir Immune Defic Syndr       Date:  2011-11-01       Impact factor: 3.731

4.  Env sequence determinants in CXCR4-using human immunodeficiency virus type-1 subtype C.

Authors:  Nina H Lin; Carlos Becerril; Francoise Giguel; Vladimir Novitsky; Sikhulile Moyo; Joseph Makhema; Myron Essex; Shahin Lockman; Daniel R Kuritzkes; Manish Sagar
Journal:  Virology       Date:  2012-09-03       Impact factor: 3.616

5.  Genetic characteristics, coreceptor usage potential and evolution of Nigerian HIV-1 subtype G and CRF02_AG isolates.

Authors:  Hannah O Ajoge; Michelle L Gordon; Tulio de Oliveira; Taryn N Green; Sani Ibrahim; Oladapo S Shittu; Stephen O Olonitola; Aliyu A Ahmad; Thumbi Ndung'u
Journal:  PLoS One       Date:  2011-03-14       Impact factor: 3.240

6.  Alterations in HIV-1 gp120 V3 region are necessary but not sufficient for coreceptor switching in CRF07_BC in China.

Authors:  Lei Zhang; Liying Ma; Zheng Wang; Yan Wang; Jing Zhang; Haining Wang; Yiming Shao
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

Review 7.  HIV-1 subtype C predicted co-receptor tropism in Africa: an individual sequence level meta-analysis.

Authors:  Nontokozo D Matume; Denis M Tebit; Pascal O Bessong
Journal:  AIDS Res Ther       Date:  2020-02-07       Impact factor: 2.250

8.  CoRSeqV3-C: a novel HIV-1 subtype C specific V3 sequence based coreceptor usage prediction algorithm.

Authors:  Kieran Cashin; Lachlan R Gray; Martin R Jakobsen; Jasminka Sterjovski; Melissa J Churchill; Paul R Gorry
Journal:  Retrovirology       Date:  2013-02-27       Impact factor: 4.602

9.  Mutations in variable domains of the HIV-1 envelope gene can have a significant impact on maraviroc and vicriviroc resistance.

Authors:  Odalis Asin-Milan; Annie Chamberland; Yi Wei; Alpha Haidara; Mohamed Sylla; Cécile L Tremblay
Journal:  AIDS Res Ther       Date:  2013-06-07       Impact factor: 2.250

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.